Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Sequencer as a Service Global Market Report 2026 | Capitalize on 20% CAGR to $5.73 Billion by 2030 as Illumina, BGI Genomics, Eurofins and Novogene Scale AI and Cloud Genomics

globenewswire.com
ILMN Illumina is mentioned as a key player in the sequencer as a service market, which is experiencing significant growth. The article does not provide specific sentiment towards Illumina's performance but lists it among prominent companies. BGI BGI Genomics is listed as a prominent company in the sequencer as a service market. The article highlights the market's growth and trends but does not offer specific sentiment or performance details for BGI Genomics.

Sequencer as a Service Global Market Report 2026 | Capitalize on 20% CAGR to $5.73 Billion by 2030 as Illumina, BGI Genomics, Eurofins and Novogene Scale AI and Cloud Genomics Dublin, Oct. 29, 2026 (GLOBE NEWSWIRE) -- "Sequencer as a Service Global Market Report 2026" has been added to ResearchAndMarkets.com's offering.

The global sequencer as a service market is experiencing rapid expansion as healthcare organizations, research institutes, biotechnology companies, and pharmaceutical developers seek flexible access to advanced genomic sequencing capabilities. The market grew from $2.31 billion in 2025 to $2.76 billion in 2026, representing a compound annual growth rate (CAGR) of 19.8%.

Historical market growth has been supported by rising demand for genomic research, limited access to in-house sequencing platforms, and the high capital cost of sequencing instruments. Expanding personalized medicine initiatives and stronger collaboration between research institutions and specialist sequencing providers have also encouraged organizations to adopt outsourced sequencing models.

The sequencer as a service market is forecast to reach $5.73 billion by 2030, expanding at a CAGR of 20%. Key growth drivers include the adoption of cloud-based sequencing solutions, increasing demand for high-throughput sequencing services, and the integration of artificial intelligence into bioinformatics analysis. The expansion of clinical genomics applications and the growing preference for outsourced sequencing services are also expected to strengthen market demand.

Prominent sequencer as a service market trends include automated sample preparation, integrated bioinformatics platforms, pay-per-use sequencing models, and scalable genomic data management. These developments enable laboratories and research organizations to increase sequencing capacity while reducing the need for substantial infrastructure investment. Cloud-based platforms are also improving collaboration, data accessibility, and analysis across geographically distributed research teams.

The rising prevalence of genetic disorders is contributing significantly to market growth. Advancing parental age and the associated risk of inherited or newly occurring genetic mutations are increasing demand for genomic testing, early detection, and accurate diagnosis. Sequencer as a service providers offer scalable access to DNA and RNA sequencing, specialist support, and cloud-based analysis while reducing operational burdens for laboratories and healthcare providers.

According to the UK National Health Service, approximately 17,000 people were living with sickle cell disease in May 2024, with around 250 new cases diagnosed annually. Growing demand for the identification and management of inherited conditions is expected to increase the use of outsourced genomic sequencing in clinical diagnostics, precision medicine, and medical research.

Market participants are strengthening sequencing quality, technical compliance, and workflow consistency through accredited service networks and AI-supported bioinformatics platforms. These initiatives are particularly relevant to genomics and single-cell analysis, where standardized sample handling and dependable sequencing workflows are essential.

In July 2024, Parse Biosciences launched its Certified Service Provider Program to expand access to scalable single-cell analysis. Through accredited providers, researchers can access end-to-end workflows supporting whole-transcriptome analysis, immune receptor sequencing, CRISPR detection, gene capture, and high-throughput gene-expression studies. The program is designed to support both pilot projects and routine large-scale single-cell research while promoting workflow standardization and reliable results.

Strategic acquisitions are also shaping the competitive environment. In February 2026, Switzerland-based life sciences venture builder Swiss Rockets AG acquired Complete Genomics Inc. for an undisclosed amount. The acquisition is intended to strengthen Swiss Rockets AG's biotechnology development portfolio, accelerate precision medicine innovation, and broaden its global sequencing technology capabilities. Complete Genomics provides outsourced sequencing services and proprietary DNBSEQ instruments, supporting the buyer's expansion across genomic research and biotechnology applications.

North America was the largest sequencer as a service market in 2025, supported by established genomics infrastructure, significant research investment, and strong adoption of precision medicine. Asia-Pacific is expected to be the fastest-growing region during the forecast period. The market analysis covers Asia-Pacific, Southeast Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. Countries covered include Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, the UK, the USA, Canada, Italy, and Spain.

Markets Covered:

1) By Component: Software; Hardware; Services

2) By Service Type: Sample Preparation Services; Library Preparation Services; Sequencing Execution Services; Bioinformatics Analysis Services; Data Storage and Management Services; Integrated End-to-End Sequencing Services

3) By Deployment Mode: Cloud-Based; On-Premises

4) By Application: Clinical Diagnostics; Oncology Research; Rare Disease Research; Infectious Disease Surveillance; Drug Discovery and Development; Agrigenomics; Forensic Genomics; Reproductive Health Testing; Personalized Medicine Research

5) By End-User: Hospitals and Clinics; Research Institutes; Pharmaceutical and Biotechnology Companies; Academic Institutions; Other End Users

Subsegments:

1) By Software: Bioinformatics Analysis Platforms; Sequence Data Management Systems; Variant Interpretation Tools; Workflow Automation Software; Cloud-Based Data Processing Platforms

2) By Hardware: High Throughput Sequencing Instruments; Sample Preparation Systems; Laboratory Automation Equipment; Data Storage Servers; High Performance Computing Infrastructure

3) By Services: Sample Processing Services; Library Preparation Services; Sequencing Execution Services; Bioinformatics Interpretation Services; Data Storage and Management Services; Consulting and Technical Support Services

Time Series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.

Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.

Key Attributes:

Companies Featured

The companies featured in this Sequencer as a Service market report include:

For more information about this report visit https://www.researchandmarkets.com/r/frt8lu

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.